Tiny Bob Langer-Backed Kite Pharma Files For $86 Million IPO
Kala Pharmaceuticals, a small Waltham biotech with two eye drugs in late-stage trials, has announced plans to raise up to $86 million in an initial public offering.
The 25-employee company, which was co-founded by MIT professor Bob Langer, said in a federal filing on Friday that it had applied to trade on the Nasdaq under the ticker “KALA.”
With the filing, Kala becomes the third Massachusetts biotech to announce plans this month for an IPO.
The 25-employee company, which was co-founded by MIT professor Bob Langer, said in a federal filing on Friday that it had applied to trade on the Nasdaq under the ticker “KALA.”
With the filing, Kala becomes the third Massachusetts biotech to announce plans this month for an IPO.